Matching slides 110,471
Current window 84,871-84,900
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all

Component

84,871-84,900 of 110,471

filter-aware
12
The map distinguishes between Middletown Valley Bank branches (circles) and Mlend offices (triangles).Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
29
Community Heritage Financial | IPO Presentation Deck | 38 slidesCommunity Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
36
The slide presents a company overview and a table of key financial metrics including loan origination volume, fulfillment services, unit counts, and purchase percentage.Community Heritage Financial | IPO Presentation Deck | 38 slides · Community Heritage Financial, Inc.
Pitch deck Investment bank 1 hit
12
The slide outlines a clinical trial protocol using a sequential phase design.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
The slide provides a scientific foundation for the CLDN6xCD3 bispecific antibody program.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
18
The slide illustrates the modular assembly of a bispecific antibody from two distinct components.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
19
The charts show dose-response curves where the proprietary antibodies (IM301, IM302) maintain high binding to CLDN6 while showing minimal off-target binding compared to the benchmark.Context Therapeutics | Investor Presentation Deck | 25 slides · Context Therapeutics
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
02
CTI BioPharma | Investor Presentation Deck | 24 slidesCTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Setup1 hit
08
Includes clinical trial data from PERSIST-2 study.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
09
The slide outlines a randomized controlled trial design for Myelofibrosis treatment.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations Beat · Evidence1 hit
23
The slide uses a three-column layout to summarize key business pillars.CTI BioPharma | Investor Presentation Deck | 24 slides · CTI BioPharma
Pitch deck Investor relations 1 hit
05
Deezer | Results Presentation Deck | 25 slidesDeezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Attention1 hit
07
The slide uses a hub-and-spoke visual layout with the Deezer logo at the center.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Interest1 hit
11
The chart uses a stacked bar format with annotations for YoY changes and percentage of revenue.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · DesireLoop · So What Cascade1 hit
16
The slide uses a stylized background image of a building with illuminated windows.Deezer | Results Presentation Deck | 25 slides · Deezer
Conference presentation Investor relations Beat · Action1 hit
06
The slide includes the KDIGO 2012 CKD prognosis matrix.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations 1 hit
08
Data sourced from the Accelerating Medicines Partnership (AMP) Lupus Network.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · Key Takeaways1 hit
11
Includes scientific citation at the bottom.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
12
The slide uses a 'Bench to Bedside' narrative structure to present scientific evidence.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
15
The slide outlines a clinical trial structure with 5 cohorts ranging from 0.4 to 3.2 mg/kg.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
16
Includes clinical trial abbreviations and source citation in footer.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide compares clinical trial data for two different drugs using different metrics (fold change vs median % reduction).Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
Equillium | Results Presentation Deck | 32 slidesEquillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide outlines a clinical trial protocol for Itolizumab in patients with active proliferative lupus nephritis (apLN).Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
24
The slide uses a structured table-like layout to categorize safety findings.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
25
The chart shows concentration over time for different dosage groups (0.4 to 3.2 mg/kg) for Type A and Type B subjects.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
31
Slide 31 of a presentation deck.Equillium | Results Presentation Deck | 32 slides · Equillium
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
03
Evercore | Investment Banking Pitch Book | 69 slidesEvercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank 1 hit
09
The slide uses a sensitivity table to show how the implied value for control changes based on different unit price premiums.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank 1 hit
12
Includes a map of the Green River Basin and a combo chart showing EBITDA vs. Sales Volume.Evercore | Investment Banking Pitch Book | 69 slides · Evercore
Consulting deck Investment bank Beat · Situation & Context1 hit